US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibrx Biosciences

11.98

-0.1800-1.48%

Pre-market: 11.40-0.5800-4.84%04:22 EDT

Volume:45.79K

Turnover:549.99K

Market Cap:173.42M

PE:0.11

High:12.74

Open:12.19

Low:11.88

Close:12.16

Loading ...

Overview Company News Filings

Inhibrx Biosciences Signs Deal With Outgoing CSO Brendan Eckelman's New Venture

MT Newswires Live

Inhibrx Biosciences Appoints New President Amid Leadership Changes

BRIEF-Inhibrx Biosciences Announces Departure Of CSO And Appointments Of New CSO And President

Inhibrx Biosciences Announces Departure of Cso and Appointments of New Cso and President

THOMSON REUTERS

Inhibrx Biosciences Inc - Enters Exclusive License Agreement With New Company

THOMSON REUTERS

Inhibrx Biosciences Inc - Appoints Carlos Bais as Cso and David Matly as President

THOMSON REUTERS

Press Release: Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President

Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

Inhibrx Q4 Net Income $(47.9)M Or $(3.09) Per Share

Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Inhibrx Biosciences Inc (INBX) Gets a Hold from JMP Securities

Inhibrx Prospective Colorectal Cancer Treatment Shows Encouraging Results, Trial Expansion Planned

MT Newswires Live

Inhibrx Biosciences Reports Promising Trial Results for INBRX-109

Inhibrx announces preliminary ozekibart data, initiates new expansion cohort

Inhibrx Biosciences Inc - Phase 1 Trial Shows 1 Complete Response, 3 Partial Responses, 6 Stable Disease Cases

THOMSON REUTERS

Inhibrx Biosciences Announces Preliminary Data From the Phase 1 Trial of Ozekibart (Inbrx-109) for the Treatment of Colorectal Cancer

THOMSON REUTERS

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

Inhibrx Biosciences Secures $150M Loan for Growth

BRIEF-Inhibrx Biosciences Announces Loan Agreement With Oxford Finance

Inhibrx Biosciences Inc - Enters $150 Million Loan Agreement With Oxford Finance

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/INBX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences","latestPrice":11.98,"timestamp":1745524800000,"preClose":12.16,"halted":0,"volume":45789,"hourTrading":{"tag":"盘前","latestPrice":11.4,"preClose":11.98,"latestTime":"04:22 EDT","volume":101,"amount":1151.310009,"timestamp":1745569358859},"delay":0,"floatShares":7712893,"shares":14475904,"eps":112.62,"marketStatus":"Pre-Mkt","change":-0.18,"latestTime":"04-25 05:06:47 EDT","open":12.19,"high":12.74,"low":11.875,"amount":549987.06,"amplitude":0.071135,"askPrice":13.9,"askSize":5,"bidPrice":4.82,"bidSize":100,"shortable":3,"etf":0,"ttmEps":112.62,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745587800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":11.98,"preHourTrading":{"tag":"盘前","latestPrice":11.4,"preClose":11.98,"latestTime":"04:22 EDT","volume":101,"amount":1151.310009,"timestamp":1745569358859},"postHourTrading":{"tag":"盘后","latestPrice":11.98,"preClose":11.98,"latestTime":"16:02 EDT","volume":924,"amount":11069.52,"timestamp":1745524933899},"volumeRatio":0.5703207519930253,"impliedVol":0.5965,"impliedVolPercentile":0.4533},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","floatShares":7712893,"roa":"-67.37%","roe":"1905.92%","lyrEps":114.009728,"volumeRatio":0.5703207519930253,"shares":14475904,"dividePrice":0,"high":12.74,"amplitude":0.071135,"preClose":12.16,"low":11.875,"week52Low":10.8,"pbRate":"1.30","psRate":"867.11","week52High":18.95,"institutionHeld":0,"latestPrice":11.98,"committee":0.904762,"eps":112.62,"divideRate":0,"volume":45789,"delay":0,"ttmEps":112.62,"open":12.19,"prevYearClose":15.4,"prevWeekClose":11.47,"prevMonthClose":13.99,"prevQuarterClose":13.99,"fiveDayClose":11.47,"twentyDayClose":14.24,"sixtyDayClose":12.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INBX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524040122","title":"Inhibrx Biosciences Signs Deal With Outgoing CSO Brendan Eckelman's New Venture","url":"https://stock-news.laohu8.com/highlight/detail?id=2524040122","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524040122?lang=en_us&edition=fundamental","pubTime":"2025-04-02 06:00","pubTimestamp":1743544811,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences  said late Tuesday that Brendan Eckelman, its co-founder and chief scientific officer, will leave the company to form a private biotechnology firm that signed an exclusive license agreement with Inhibrx.The deal is for the rights to certain technologies no longer being pursued by Inhibrx. The pact includes an upfront payment upon completion of the initial funding of Eckelman's new company and other future development milestones.Carlos Bais, Inhibrx's executive vice president of translational sciences, will be appointed chief scientific officer and David Matly will become president, in addition to his existing role as chief commercial and business development officer.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2524121943","title":"Inhibrx Biosciences Appoints New President Amid Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2524121943","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524121943?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:27","pubTimestamp":1743539246,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Inc ( ($INBX) ) just unveiled an update. On April 1, 2025, Inhibrx Biosciences, Inc. announced the appointment of David J. Matl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-appoints-new-president-amid-leadership-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-appoints-new-president-amid-leadership-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2524837129","title":"BRIEF-Inhibrx Biosciences Announces Departure Of CSO And Appointments Of New CSO And President","url":"https://stock-news.laohu8.com/highlight/detail?id=2524837129","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524837129?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:06","pubTimestamp":1743537984,"startTime":"0","endTime":"0","summary":"BRIEF-Inhibrx Biosciences Announces Departure Of CSO And Appointments Of New CSO And PresidentApril 1 (Reuters) - Inhibrx Biosciences Inc INBX.O:INHIBRX BIOSCIENCES ANNOUNCES DEPARTURE OF CSO AND APPO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUABDDVWF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2524126097","title":"Inhibrx Biosciences Announces Departure of Cso and Appointments of New Cso and President","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126097","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126097?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:05","pubTimestamp":1743537902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUABDDVWF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2524126040","title":"Inhibrx Biosciences Inc - Enters Exclusive License Agreement With New Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126040","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126040?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:05","pubTimestamp":1743537902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUABDDVWF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2524126019","title":"Inhibrx Biosciences Inc - Appoints Carlos Bais as Cso and David Matly as President","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126019","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126019?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:05","pubTimestamp":1743537902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUABDDVWF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2524126006","title":"Press Release: Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126006","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126006?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:05","pubTimestamp":1743537900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, April 1, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc.  , a clinical-stage biopharmaceutical company with two programs in clinical-stage development, today announced the departure of Dr. Brendan Eckelman, co-founder and Chief Scientific Officer  and the appointments of Dr. Carlos Bais and David Matly to CSO and President, respectively.\"We believe we are exceptionally well-positioned for continued success as Carlos steps into the role of CSO and David into the role of President,\" continued Mr. Lappe. \"Carlos's strong scientific background and expertise in late-stage development make him a perfect candidate to assume the CSO role. And David's cross-functional understanding of successfully delivering best-in-class new therapies, combined with his ambition and commitment to the Company will prove to be pivotal to our future success. Each will play a crucial role as we continue to execute on our clinical programs in an effort to deliver significant impact to patients while","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2520904039","title":"Inhibrx Biosciences Full Year 2024 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2520904039","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520904039?lang=en_us&edition=fundamental","pubTime":"2025-03-19 18:58","pubTimestamp":1742381882,"startTime":"0","endTime":"0","summary":"NasdaqGS:INBX Earnings and Revenue History March 19th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 100%. Earnings per share  also surpassed analyst estimates by 7.4%.The company's shares are up 2.9% from a week ago.You still need to take note of risks, for example - Inhibrx Biosciences has   3 warning signs    we think you should know about.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inhibrx-biosciences-full-2024-earnings-105802039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INBX"],"gpt_icon":0},{"id":"2520688598","title":"Inhibrx Q4 Net Income $(47.9)M Or $(3.09) Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2520688598","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520688598?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:10","pubTimestamp":1742242203,"startTime":"0","endTime":"0","summary":"Because the spin-off was accounted for as a reverse spin-off, for periods prior to the spin-off, the Company&#39;s financial statements are the historical financial statements of the Former Parent.Net loss was $93.6 million","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44364284/inhibrx-q4-net-income-47-9-m-or-3-09-per-share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2520880146","title":"Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2520880146","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520880146?lang=en_us&edition=fundamental","pubTime":"2025-03-18 04:05","pubTimestamp":1742241900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 17, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc.   today reported financial results for the fourth quarter and fiscal year 2024. Following the completion of the sale of INBRX-101 by Inhibrx, Inc.  to Sanofi S.A.  and the Former Parent's concurrent spin-off of the Inhibrx business in May 2024, the biopharmaceutical company now has two programs in ongoing clinical trials, with data readouts for each expected within the next 12 months. Because the spin-off was accounted for as a reverse spin-off, for periods prior to the spin-off, the Company's financial statements are the historical financial statements of the Former Parent.Cash and Cash Equivalents. As of December31, 2024, Inhibrx had cash and cash equivalents of $152.6 million. Subsequent to year-end, the Company entered into the Oxford Loan Agreement and received gross proceeds of $100.0 million. As of February 28, 2025, Inhibrx had cash and cash equivalents of $230.5 million.Research and development expenses were $","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inhibrx-reports-fourth-quarter-fiscal-200500270.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inhibrx-reports-fourth-quarter-fiscal-200500270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0456854461.SGD","CRC","BK4195","BK4213","BK4211","LU0266512127.USD","BK4139","INBX","SOFR","PFS"],"gpt_icon":0},{"id":"2505176170","title":"Inhibrx Biosciences Inc (INBX) Gets a Hold from JMP Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2505176170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505176170?lang=en_us&edition=fundamental","pubTime":"2025-01-22 13:45","pubTimestamp":1737524749,"startTime":"0","endTime":"0","summary":"In a report released today, Reni Benjamin from JMP Securities maintained a Hold rating on Inhibrx Biosciences Inc (INBX – Research Report). The com...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/inhibrx-biosciences-inc-inbx-gets-a-hold-from-jmp-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/inhibrx-biosciences-inc-inbx-gets-a-hold-from-jmp-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","JMP","BK4139","INBX"],"gpt_icon":0},{"id":"2505359587","title":"Inhibrx Prospective Colorectal Cancer Treatment Shows Encouraging Results, Trial Expansion Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2505359587","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505359587?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:48","pubTimestamp":1737499691,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences (INBX) late Tuesday released preliminary safety and efficacy data from phase 1 testing of its ozekibart drug candidate, with four patients with advanced or metastatic unresectable ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2505355367","title":"Inhibrx Biosciences Reports Promising Trial Results for INBRX-109","url":"https://stock-news.laohu8.com/highlight/detail?id=2505355367","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505355367?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:29","pubTimestamp":1737498560,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Inc ( ($INBX) ) has shared an update. On January 21, 2025, Inhibrx Biosciences announced preliminary results from a Phase 1 tri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-promising-trial-results-for-inbrx-109?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-promising-trial-results-for-inbrx-109?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2505840733","title":"Inhibrx announces preliminary ozekibart data, initiates new expansion cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2505840733","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505840733?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:10","pubTimestamp":1737497415,"startTime":"0","endTime":"0","summary":"Inhibrx (INBX) announced preliminary efficacy and safety data from the Phase 1 trial of ozekibart in combination with Folfiri for the treatment of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inhibrx-announces-preliminary-ozekibart-data-initiates-new-expansion-cohort?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inhibrx-announces-preliminary-ozekibart-data-initiates-new-expansion-cohort?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2505780426","title":"Inhibrx Biosciences Inc - Phase 1 Trial Shows 1 Complete Response, 3 Partial Responses, 6 Stable Disease Cases","url":"https://stock-news.laohu8.com/highlight/detail?id=2505780426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505780426?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:01","pubTimestamp":1737496863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUABFL2JL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2505780420","title":"Inhibrx Biosciences Announces Preliminary Data From the Phase 1 Trial of Ozekibart (Inbrx-109) for the Treatment of Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2505780420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505780420?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:01","pubTimestamp":1737496863,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUABFL2JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2505278023","title":"Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2505278023","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505278023?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:01","pubTimestamp":1737496860,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Jan. 21, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc.  , a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced preliminary efficacy and safety data from the Phase 1 trial of ozekibart  in combination with FOLFIRI for the treatment of advanced or metastatic, unresectable colorectal adenocarcinoma . These results were presented at the American Society of Clinical Oncology  Gastrointestinal Annual Cancers Symposium.Ozekibart-related treatment-emergent adverse events  were reported in 84.6% of patients, with most being grade 1 or 2 in severity. Grade ≥3 TEAEs were observed in 30.8% of patients. The most common ozekibart-related TEAEs included nausea, increased alanine aminotransferase, diarrhea, and fatigue, with the majority being low-grade.Ozekibart is a precision-engineered, tetravalent death receptor 5  agonist antibody designed to exploit the tumor-biased cell death induced by DR5 activation.In Januar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inhibrx-biosciences-announces-preliminary-data-220100477.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inhibrx-biosciences-announces-preliminary-data-220100477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRC","CR","BK4195","PFS","BK4139","LU0456854461.SGD","INBX","PR","LU0266512127.USD","SD","BK4213","BK4211","BK4161"],"gpt_icon":0},{"id":"2503560435","title":"Inhibrx Biosciences Secures $150M Loan for Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2503560435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503560435?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:50","pubTimestamp":1736805023,"startTime":"0","endTime":"0","summary":"An update from Inhibrx Biosciences Inc ( ($INBX) ) is now available. Inhibrx Biosciences, Inc. announced a loan and security agreement with Oxford ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-secures-150m-loan-for-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-secures-150m-loan-for-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2503355596","title":"BRIEF-Inhibrx Biosciences Announces Loan Agreement With Oxford Finance","url":"https://stock-news.laohu8.com/highlight/detail?id=2503355596","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503355596?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:24","pubTimestamp":1736803463,"startTime":"0","endTime":"0","summary":"BRIEF-Inhibrx Biosciences Announces Loan Agreement With Oxford FinanceJan 13 (Reuters) - Inhibrx Biosciences INBX.O:INHIBRX BIOSCIENCES ANNOUNCES LOAN AGREEMENT WITH OXFORD FINANCEINHIBRX BIOSCIENCES ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA9GDD89:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2503558675","title":"Inhibrx Biosciences Inc - Enters $150 Million Loan Agreement With Oxford Finance","url":"https://stock-news.laohu8.com/highlight/detail?id=2503558675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503558675?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:15","pubTimestamp":1736802904,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA9GDD89:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-17","symbol":"INBX","fiscalQuarterEnding":"2024/12","expectedEps":-2.88,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":-3.09},{"market":"US","date":"2024-11-14","symbol":"INBX","fiscalQuarterEnding":"2024/09","expectedEps":-3.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-2.84},{"market":"US","date":"2024-08-13","symbol":"INBX","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":125.48},{"market":"US","date":"2024-05-31","symbol":"INBX","reason":null,"defaultRemindTime":1717162200000,"announcedDate":"2024-05-17","type":"delisting","dateTimestamp":1717128000000},{"market":"US","date":"2024-05-09","symbol":"INBX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1723608000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INBX","date":"2025-04-23","current":0.10182,"percent":0.858885,"low":-25.215559,"twenty":-12.555597,"median":-8.026649,"eighty":-4.450293,"high":0.147174,"avg":-8.258653,"sd":5.598953,"marketCap":171828980},"quantilePoints":[{"date":"2020-08-21","current":-10.074177,"twenty":-8.974965,"median":-8.691736,"eighty":-8.57594,"marketCap":749982174},{"date":"2020-08-28","current":-8.303923,"twenty":-9.68265,"median":-8.695949,"eighty":-8.558026,"marketCap":618193823},{"date":"2020-09-04","current":-8.821685,"twenty":-9.172778,"median":-8.691736,"eighty":-8.47651,"marketCap":656739162},{"date":"2020-09-11","current":-8.43213,"twenty":-9.392703,"median":-8.691736,"eighty":-8.435089,"marketCap":627738383},{"date":"2020-09-18","current":-8.496234,"twenty":-9.156998,"median":-8.600191,"eighty":-8.466648,"marketCap":632510663},{"date":"2020-09-25","current":-8.940031,"twenty":-9.076129,"median":-8.624442,"eighty":-8.492289,"marketCap":665549526},{"date":"2020-10-02","current":-8.599787,"twenty":-9.059363,"median":-8.658089,"eighty":-8.513986,"marketCap":640219731},{"date":"2020-10-09","current":-8.944962,"twenty":-8.988355,"median":-8.624442,"eighty":-8.513986,"marketCap":665916624},{"date":"2020-10-16","current":-8.649098,"twenty":-9.059363,"median":-8.695949,"eighty":-8.52878,"marketCap":643890716},{"date":"2020-10-23","current":-9.438069,"twenty":-9.104728,"median":-8.742788,"eighty":-8.533711,"marketCap":702626471},{"date":"2020-10-30","current":-8.402544,"twenty":-9.282247,"median":-8.75265,"eighty":-8.52878,"marketCap":625535792},{"date":"2020-11-06","current":-9.383827,"twenty":-9.33353,"median":-8.762512,"eighty":-8.52878,"marketCap":698588388},{"date":"2020-11-13","current":-10.111439,"twenty":-9.374951,"median":-8.824151,"eighty":-8.533711,"marketCap":756133419},{"date":"2020-11-20","current":-12.658211,"twenty":-9.516966,"median":-8.861134,"eighty":-8.547517,"marketCap":946580989},{"date":"2020-11-27","current":-14.524162,"twenty":-9.639257,"median":-8.89072,"eighty":-8.555407,"marketCap":1086116832},{"date":"2020-12-04","current":-18.387186,"twenty":-10.064315,"median":-8.999204,"eighty":-8.557379,"marketCap":1374993739},{"date":"2020-12-11","current":-19.35042,"twenty":-11.267143,"median":-9.068239,"eighty":-8.560338,"marketCap":1447024404},{"date":"2020-12-18","current":-23.869048,"twenty":-12.978952,"median":-9.105221,"eighty":-8.566579,"marketCap":1784927418},{"date":"2020-12-24","current":-22.340985,"twenty":-14.395058,"median":-9.287671,"eighty":-8.57594,"marketCap":1670658877},{"date":"2020-12-31","current":-16.62714,"twenty":-16.647312,"median":-9.334516,"eighty":-8.57594,"marketCap":1243377498},{"date":"2021-01-08","current":-17.222227,"twenty":-17.222227,"median":-9.369034,"eighty":-8.599787,"marketCap":1287878118},{"date":"2021-01-15","current":-16.959985,"twenty":-17.277701,"median":-9.424258,"eighty":-8.604718,"marketCap":1268267675},{"date":"2021-01-22","current":-18.367013,"twenty":-17.627693,"median":-9.529294,"eighty":-8.608663,"marketCap":1373485243},{"date":"2021-01-29","current":-15.986664,"twenty":-17.452193,"median":-9.630381,"eighty":-8.621483,"marketCap":1195482763},{"date":"2021-02-05","current":-19.678222,"twenty":-17.724521,"median":-9.859675,"eighty":-8.624442,"marketCap":1471537457},{"date":"2021-02-12","current":-16.889381,"twenty":-17.941375,"median":-10.074177,"eighty":-8.644167,"marketCap":1262987941},{"date":"2021-02-19","current":-13.480238,"twenty":-17.863711,"median":-10.414026,"eighty":-8.674681,"marketCap":1008052184},{"date":"2021-02-26","current":-12.81959,"twenty":-17.793107,"median":-11.725235,"eighty":-8.696792,"marketCap":958648953},{"date":"2021-03-05","current":-13.308772,"twenty":-17.73259,"median":-12.274934,"eighty":-8.725738,"marketCap":995229972},{"date":"2021-03-12","current":-11.657921,"twenty":-17.668038,"median":-11.894179,"eighty":-8.754622,"marketCap":887447580},{"date":"2021-03-19","current":-10.988496,"twenty":-17.62971,"median":-11.861399,"eighty":-8.783223,"marketCap":836488234},{"date":"2021-03-26","current":-8.955426,"twenty":-17.495564,"median":-11.667839,"eighty":-8.811823,"marketCap":681722811},{"date":"2021-04-01","current":-10.16535,"twenty":-17.392684,"median":-11.384825,"eighty":-8.776319,"marketCap":773827112},{"date":"2021-04-09","current":-10.16535,"twenty":-17.332167,"median":-10.784251,"eighty":-8.806892,"marketCap":773827112},{"date":"2021-04-16","current":-8.940549,"twenty":-17.271649,"median":-10.681055,"eighty":-8.823657,"marketCap":680590381},{"date":"2021-04-23","current":-9.411627,"twenty":-17.246434,"median":-10.552129,"eighty":-8.828588,"marketCap":716450662},{"date":"2021-04-30","current":-10.594488,"twenty":-17.204072,"median":-10.445517,"eighty":-8.843382,"marketCap":806494786},{"date":"2021-05-07","current":-7.842802,"twenty":-17.16877,"median":-10.413285,"eighty":-8.806892,"marketCap":597025442},{"date":"2021-05-14","current":-8.388445,"twenty":-17.077994,"median":-10.267003,"eighty":-8.695106,"marketCap":631817649},{"date":"2021-05-21","current":-8.418565,"twenty":-16.931743,"median":-10.16535,"eighty":-8.624442,"marketCap":634086294},{"date":"2021-05-28","current":-10.622351,"twenty":-16.840967,"median":-10.138395,"eighty":-8.634304,"marketCap":800075491},{"date":"2021-06-04","current":-10.978772,"twenty":-16.758261,"median":-10.16535,"eighty":-8.657626,"marketCap":826921124},{"date":"2021-06-11","current":-12.248836,"twenty":-16.703795,"median":-10.324029,"eighty":-8.693326,"marketCap":922582324},{"date":"2021-06-18","current":-13.338179,"twenty":-16.643278,"median":-10.413656,"eighty":-8.699781,"marketCap":1004631654},{"date":"2021-06-25","current":-12.966698,"twenty":-16.59789,"median":-10.452955,"eighty":-8.708687,"marketCap":976651698},{"date":"2021-07-02","current":-15.562046,"twenty":-16.480889,"median":-10.58834,"eighty":-8.746733,"marketCap":1172133281},{"date":"2021-07-09","current":-14.337162,"twenty":-16.480889,"median":-10.601716,"eighty":-8.762512,"marketCap":1079875048},{"date":"2021-07-16","current":-12.700637,"twenty":-16.369941,"median":-10.760395,"eighty":-8.79703,"marketCap":956612000},{"date":"2021-07-23","current":-14.558043,"twenty":-15.986664,"median":-10.983634,"eighty":-8.821685,"marketCap":1096511779},{"date":"2021-07-30","current":-14.286962,"twenty":-15.764767,"median":-11.079173,"eighty":-8.826616,"marketCap":1076093973},{"date":"2021-08-06","current":-13.73476,"twenty":-15.562046,"median":-11.384825,"eighty":-8.831547,"marketCap":1034502147},{"date":"2021-08-13","current":-13.397679,"twenty":-15.511846,"median":-11.677756,"eighty":-8.861134,"marketCap":1046961596},{"date":"2021-08-20","current":-13.800142,"twenty":-15.336145,"median":-11.861847,"eighty":-8.875927,"marketCap":1078412125},{"date":"2021-08-27","current":-14.469299,"twenty":-15.305844,"median":-11.921916,"eighty":-8.89072,"marketCap":1130703367},{"date":"2021-09-03","current":-15.225737,"twenty":-15.25037,"median":-12.221226,"eighty":-8.940031,"marketCap":1189815205},{"date":"2021-09-10","current":-16.530107,"twenty":-15.521886,"median":-12.271925,"eighty":-8.940445,"marketCap":1291745234},{"date":"2021-09-17","current":-17.950853,"twenty":-15.909368,"median":-12.434577,"eighty":-8.944079,"marketCap":1402769392},{"date":"2021-09-24","current":-17.829629,"twenty":-16.480889,"median":-12.612787,"eighty":-8.953333,"marketCap":1393296341},{"date":"2021-10-01","current":-15.730029,"twenty":-16.490733,"median":-12.663254,"eighty":-8.96336,"marketCap":1229223097},{"date":"2021-10-08","current":-12.97097,"twenty":-16.480889,"median":-12.827884,"eighty":-9.035825,"marketCap":1013616457},{"date":"2021-10-15","current":-19.255223,"twenty":-16.545624,"median":-12.97097,"eighty":-9.054369,"marketCap":1504699420},{"date":"2021-10-22","current":-18.493936,"twenty":-16.728002,"median":-13.052038,"eighty":-9.0546,"marketCap":1445208660},{"date":"2021-10-29","current":-19.487973,"twenty":-16.918658,"median":-13.192599,"eighty":-9.065511,"marketCap":1522887678},{"date":"2021-11-05","current":-21.694251,"twenty":-17.230296,"median":-13.217847,"eighty":-9.068239,"marketCap":1695297206},{"date":"2021-11-12","current":-20.979364,"twenty":-17.376546,"median":-13.248255,"eighty":-9.084018,"marketCap":1641173724},{"date":"2021-11-19","current":-21.018179,"twenty":-17.627693,"median":-13.306251,"eighty":-9.093008,"marketCap":1644210123},{"date":"2021-11-26","current":-18.59711,"twenty":-17.724892,"median":-13.36308,"eighty":-9.09439,"marketCap":1454814728},{"date":"2021-12-03","current":-17.903297,"twenty":-17.836807,"median":-13.397679,"eighty":-9.099442,"marketCap":1400539094},{"date":"2021-12-10","current":-19.009517,"twenty":-17.922319,"median":-13.461918,"eighty":-9.105715,"marketCap":1487076469},{"date":"2021-12-17","current":-21.411178,"twenty":-18.339089,"median":-13.523752,"eighty":-9.141289,"marketCap":1674953664},{"date":"2021-12-23","current":-21.576141,"twenty":-18.404686,"median":-13.538298,"eighty":-9.19146,"marketCap":1687858360},{"date":"2021-12-31","current":-21.187994,"twenty":-18.643832,"median":-13.635278,"eighty":-9.244088,"marketCap":1657494369},{"date":"2022-01-07","current":-16.535077,"twenty":-18.65535,"median":-13.71468,"eighty":-9.282247,"marketCap":1293506025},{"date":"2022-01-14","current":-15.273598,"twenty":-18.643832,"median":-13.796526,"eighty":-9.316764,"marketCap":1194823053},{"date":"2022-01-21","current":-13.614268,"twenty":-18.628162,"median":-13.763835,"eighty":-9.324228,"marketCap":1065016991},{"date":"2022-01-28","current":-11.940383,"twenty":-18.576475,"median":-13.688616,"eighty":-9.34366,"marketCap":934072279},{"date":"2022-02-04","current":-12.561419,"twenty":-18.478419,"median":-13.607802,"eighty":-9.350296,"marketCap":982654665},{"date":"2022-02-11","current":-11.285384,"twenty":-18.41052,"median":-13.552845,"eighty":-9.3572,"marketCap":882833044},{"date":"2022-02-18","current":-10.460571,"twenty":-18.383151,"median":-13.530363,"eighty":-9.371993,"marketCap":818309562},{"date":"2022-02-25","current":-10.741978,"twenty":-18.367013,"median":-13.519646,"eighty":-9.383827,"marketCap":840323456},{"date":"2022-03-04","current":-9.688638,"twenty":-18.346841,"median":-13.443599,"eighty":-9.410447,"marketCap":792220573},{"date":"2022-03-11","current":-10.270911,"twenty":-18.333921,"median":-13.396092,"eighty":-9.411627,"marketCap":839831858},{"date":"2022-03-18","current":-12.055911,"twenty":-18.155202,"median":-13.338179,"eighty":-9.438069,"marketCap":985787767},{"date":"2022-03-25","current":-10.30432,"twenty":-18.141037,"median":-13.280794,"eighty":-9.467655,"marketCap":842563653},{"date":"2022-04-01","current":-11.182502,"twenty":-18.091473,"median":-13.235825,"eighty":-9.492956,"marketCap":914370838},{"date":"2022-04-08","current":-10.084775,"twenty":-18.029445,"median":-13.217847,"eighty":-9.550229,"marketCap":824611857},{"date":"2022-04-14","current":-8.743823,"twenty":-17.966571,"median":-13.19269,"eighty":-9.432781,"marketCap":714964912},{"date":"2022-04-22","current":-7.813121,"twenty":-17.912808,"median":-13.077138,"eighty":-9.380868,"marketCap":638863297},{"date":"2022-04-29","current":-7.564934,"twenty":-17.890994,"median":-13.002219,"eighty":-9.337742,"marketCap":618569533},{"date":"2022-05-06","current":-7.426522,"twenty":-17.855642,"median":-12.966698,"eighty":-9.255063,"marketCap":607251857},{"date":"2022-05-13","current":-7.055067,"twenty":-17.833218,"median":-12.861335,"eighty":-9.106701,"marketCap":661292590},{"date":"2022-05-20","current":-5.626562,"twenty":-17.771363,"median":-12.813715,"eighty":-9.084018,"marketCap":527394503},{"date":"2022-05-27","current":-5.684868,"twenty":-17.745237,"median":-12.660732,"eighty":-9.054369,"marketCap":532859731},{"date":"2022-06-03","current":-4.801943,"twenty":-17.737028,"median":-12.627593,"eighty":-8.95124,"marketCap":450100564},{"date":"2022-06-10","current":-4.089773,"twenty":-17.730073,"median":-12.561419,"eighty":-8.884803,"marketCap":383346708},{"date":"2022-06-17","current":-3.781583,"twenty":-17.724892,"median":-12.459267,"eighty":-8.824644,"marketCap":354459074},{"date":"2022-06-24","current":-4.881073,"twenty":-17.720352,"median":-12.408239,"eighty":-8.7684,"marketCap":457517659},{"date":"2022-07-01","current":-4.822767,"twenty":-17.684176,"median":-12.274934,"eighty":-8.715717,"marketCap":452052431},{"date":"2022-07-08","current":-7.17168,"twenty":-17.633745,"median":-12.248836,"eighty":-8.692608,"marketCap":672223046},{"date":"2022-07-15","current":-7.196668,"twenty":-17.617007,"median":-12.144125,"eighty":-8.612608,"marketCap":674565287},{"date":"2022-07-22","current":-8.458584,"twenty":-17.576513,"median":-12.055911,"eighty":-8.581377,"marketCap":792848436},{"date":"2022-07-29","current":-7.221656,"twenty":-17.524355,"median":-11.894179,"eighty":-8.56331,"marketCap":676907527},{"date":"2022-08-05","current":-9.512263,"twenty":-17.400753,"median":-11.861399,"eighty":-8.555407,"marketCap":891612914},{"date":"2022-08-12","current":-8.625805,"twenty":-17.350322,"median":-11.769735,"eighty":-8.539628,"marketCap":955350999},{"date":"2022-08-19","current":-6.788501,"twenty":-17.27656,"median":-11.657921,"eighty":-8.520336,"marketCap":751860455},{"date":"2022-08-26","current":-6.933087,"twenty":-17.270113,"median":-11.575505,"eighty":-8.459312,"marketCap":767874106},{"date":"2022-09-02","current":-5.698815,"twenty":-17.254503,"median":-11.411593,"eighty":-8.433116,"marketCap":631172205},{"date":"2022-09-09","current":-5.543649,"twenty":-17.222227,"median":-11.316139,"eighty":-8.402544,"marketCap":613986823},{"date":"2022-09-16","current":-5.099311,"twenty":-17.176839,"median":-11.219387,"eighty":-8.38282,"marketCap":564774139},{"date":"2022-09-23","current":-5.205105,"twenty":-17.156666,"median":-11.106139,"eighty":-8.343685,"marketCap":576491445},{"date":"2022-09-30","current":-6.330057,"twenty":-16.959985,"median":-11.073112,"eighty":-8.269405,"marketCap":701085463},{"date":"2022-10-07","current":-10.755807,"twenty":-16.908326,"median":-11.043041,"eighty":-8.269405,"marketCap":1191259423},{"date":"2022-10-14","current":-10.526585,"twenty":-16.889381,"median":-10.983634,"eighty":-8.297841,"marketCap":1165871927},{"date":"2022-10-21","current":-10.932132,"twenty":-16.806498,"median":-10.958184,"eighty":-8.303923,"marketCap":1210788266},{"date":"2022-10-28","current":-11.542215,"twenty":-16.768347,"median":-10.953974,"eighty":-8.322526,"marketCap":1278358062},{"date":"2022-11-04","current":-10.914499,"twenty":-16.717916,"median":-10.967397,"eighty":-8.343685,"marketCap":1208835381},{"date":"2022-11-11","current":-11.344191,"twenty":-16.647312,"median":-10.962791,"eighty":-8.354397,"marketCap":1423695985},{"date":"2022-11-18","current":-10.049794,"twenty":-16.62714,"median":-10.967397,"eighty":-8.354465,"marketCap":1261249181},{"date":"2022-11-25","current":-10.525216,"twenty":-16.611581,"median":-10.949764,"eighty":-8.365585,"marketCap":1320914629},{"date":"2022-12-02","current":-11.278257,"twenty":-16.580652,"median":-10.937999,"eighty":-8.379929,"marketCap":1415421215},{"date":"2022-12-09","current":-9.435563,"twenty":-16.54284,"median":-10.900911,"eighty":-8.38732,"marketCap":1184163164},{"date":"2022-12-16","current":-9.373099,"twenty":-16.531101,"median":-10.878658,"eighty":-8.393763,"marketCap":1176323908},{"date":"2022-12-23","current":-8.609648,"twenty":-16.490733,"median":-10.784251,"eighty":-8.401054,"marketCap":1080510779},{"date":"2022-12-30","current":-8.550654,"twenty":-16.480889,"median":-10.755807,"eighty":-8.386195,"marketCap":1073107038},{"date":"2023-01-06","current":-8.026649,"twenty":-16.471483,"median":-10.69346,"eighty":-8.360025,"marketCap":1007344390},{"date":"2023-01-13","current":-8.210571,"twenty":-16.426351,"median":-10.672935,"eighty":-8.338773,"marketCap":1030426644},{"date":"2023-01-20","current":-8.391023,"twenty":-16.377843,"median":-10.653608,"eighty":-8.307919,"marketCap":1053073383},{"date":"2023-01-27","current":-9.418212,"twenty":-16.362213,"median":-10.622351,"eighty":-8.325121,"marketCap":1181985593},{"date":"2023-02-03","current":-8.953201,"twenty":-16.33033,"median":-10.598102,"eighty":-8.337136,"marketCap":1123626687},{"date":"2023-02-10","current":-8.016238,"twenty":-16.291538,"median":-10.582191,"eighty":-8.307919,"marketCap":1006037848},{"date":"2023-02-17","current":-8.311208,"twenty":-16.132459,"median":-10.5517,"eighty":-8.275092,"marketCap":1043056556},{"date":"2023-02-24","current":-8.030119,"twenty":-16.054745,"median":-10.525901,"eighty":-8.231392,"marketCap":1007779905},{"date":"2023-03-03","current":-8.387553,"twenty":-15.986664,"median":-10.497454,"eighty":-8.231392,"marketCap":1052637869},{"date":"2023-03-10","current":-6.435629,"twenty":-15.890044,"median":-10.456763,"eighty":-8.19669,"marketCap":934620687},{"date":"2023-03-17","current":-6.270613,"twenty":-15.797914,"median":-10.414026,"eighty":-8.099523,"marketCap":910656054},{"date":"2023-03-24","current":-5.790566,"twenty":-15.764767,"median":-10.407228,"eighty":-8.067817,"marketCap":840940758},{"date":"2023-03-31","current":-5.661554,"twenty":-15.730029,"median":-10.399775,"eighty":-8.033589,"marketCap":822204772},{"date":"2023-04-06","current":-5.208509,"twenty":-15.644351,"median":-10.35682,"eighty":-8.023608,"marketCap":756410961},{"date":"2023-04-14","current":-5.499418,"twenty":-15.574223,"median":-10.30432,"eighty":-7.994722,"marketCap":798658421},{"date":"2023-04-21","current":-5.892662,"twenty":-15.521886,"median":-10.270911,"eighty":-7.963641,"marketCap":855767729},{"date":"2023-04-28","current":-6.192849,"twenty":-15.371285,"median":-10.226889,"eighty":-7.840005,"marketCap":899362621},{"date":"2023-05-05","current":-8.07802,"twenty":-15.311904,"median":-10.209425,"eighty":-7.808348,"marketCap":1173138543},{"date":"2023-05-12","current":-6.709665,"twenty":-15.280047,"median":-10.16535,"eighty":-7.729148,"marketCap":1092923942},{"date":"2023-05-19","current":-6.50133,"twenty":-15.255016,"median":-10.150431,"eighty":-7.546255,"marketCap":1058988661},{"date":"2023-05-26","current":-6.166624,"twenty":-15.230664,"median":-10.123541,"eighty":-7.399027,"marketCap":1004469064},{"date":"2023-06-02","current":-6.482587,"twenty":-15.150093,"median":-10.101438,"eighty":-7.301546,"marketCap":1055935564},{"date":"2023-06-09","current":-6.578982,"twenty":-15.099664,"median":-10.081052,"eighty":-7.190357,"marketCap":1071637208},{"date":"2023-06-16","current":-7.449218,"twenty":-15.081916,"median":-10.06194,"eighty":-7.181675,"marketCap":1213388161},{"date":"2023-06-23","current":-7.130577,"twenty":-15.043354,"median":-10.049658,"eighty":-7.147018,"marketCap":1161485505},{"date":"2023-06-30","current":-6.889589,"twenty":-14.978471,"median":-10.010787,"eighty":-7.109449,"marketCap":1122231394},{"date":"2023-07-07","current":-6.694121,"twenty":-14.879324,"median":-10.003176,"eighty":-7.080055,"marketCap":1090391950},{"date":"2023-07-14","current":-6.71822,"twenty":-14.813575,"median":-9.929589,"eighty":-7.055067,"marketCap":1094317361},{"date":"2023-07-21","current":-6.734286,"twenty":-14.720843,"median":-9.757019,"eighty":-7.020794,"marketCap":1096934301},{"date":"2023-07-28","current":-5.612351,"twenty":-14.603223,"median":-9.723592,"eighty":-6.959208,"marketCap":914184610},{"date":"2023-08-04","current":-5.398139,"twenty":-14.56955,"median":-9.684017,"eighty":-6.913688,"marketCap":879292068},{"date":"2023-08-11","current":-4.03189,"twenty":-14.558043,"median":-9.636138,"eighty":-6.825667,"marketCap":694323632},{"date":"2023-08-18","current":-4.184036,"twenty":-14.524162,"median":-9.629385,"eighty":-6.795871,"marketCap":720524524},{"date":"2023-08-25","current":-4.754587,"twenty":-14.503242,"median":-9.590932,"eighty":-6.760289,"marketCap":818777868},{"date":"2023-09-01","current":-5.426568,"twenty":-14.469299,"median":-9.50261,"eighty":-6.734286,"marketCap":934498474},{"date":"2023-09-08","current":-5.464605,"twenty":-14.447925,"median":-9.46202,"eighty":-6.706556,"marketCap":941048697},{"date":"2023-09-15","current":-5.071559,"twenty":-14.422502,"median":-9.438069,"eighty":-6.644838,"marketCap":873363060},{"date":"2023-09-22","current":-4.949842,"twenty":-14.389111,"median":-9.414919,"eighty":-6.609239,"marketCap":852402346},{"date":"2023-09-29","current":-4.617655,"twenty":-14.346133,"median":-9.407047,"eighty":-6.577375,"marketCap":795197066},{"date":"2023-10-06","current":-4.749515,"twenty":-14.31098,"median":-9.378463,"eighty":-6.507756,"marketCap":817904505},{"date":"2023-10-13","current":-4.513688,"twenty":-14.290456,"median":-9.369034,"eighty":-6.480396,"marketCap":777293123},{"date":"2023-10-20","current":-4.009068,"twenty":-14.254834,"median":-9.345778,"eighty":-6.435381,"marketCap":690393498},{"date":"2023-10-27","current":-3.867064,"twenty":-14.245721,"median":-9.330985,"eighty":-6.382845,"marketCap":665939333},{"date":"2023-11-03","current":-4.062319,"twenty":-14.23073,"median":-9.300224,"eighty":-6.304458,"marketCap":699563811},{"date":"2023-11-10","current":-4.235537,"twenty":-14.186119,"median":-9.266506,"eighty":-6.270701,"marketCap":799127199},{"date":"2023-11-17","current":-5.26616,"twenty":-14.175985,"median":-9.233113,"eighty":-6.246101,"marketCap":993576892},{"date":"2023-11-24","current":-5.148354,"twenty":-14.166482,"median":-9.221106,"eighty":-6.167838,"marketCap":971350279},{"date":"2023-12-01","current":-5.206004,"twenty":-14.131341,"median":-9.105221,"eighty":-6.111798,"marketCap":982227132},{"date":"2023-12-08","current":-6.356488,"twenty":-14.04259,"median":-9.094269,"eighty":-6.096789,"marketCap":1199291289},{"date":"2023-12-15","current":-6.902905,"twenty":-14.028044,"median":-9.068239,"eighty":-6.096789,"marketCap":1302384941},{"date":"2023-12-22","current":-7.489427,"twenty":-14.025921,"median":-9.0546,"eighty":-6.100835,"marketCap":1413045100},{"date":"2023-12-29","current":-8.757716,"twenty":-14.008907,"median":-9.009394,"eighty":-6.107413,"marketCap":1652335870},{"date":"2024-01-05","current":-9.281575,"twenty":-13.987173,"median":-9.0546,"eighty":-6.120086,"marketCap":1751173361},{"date":"2024-01-12","current":-9.274056,"twenty":-13.943671,"median":-9.061419,"eighty":-6.154509,"marketCap":1749754642},{"date":"2024-01-19","current":-8.211299,"twenty":-13.935913,"median":-9.054023,"eighty":-6.159602,"marketCap":1549242218},{"date":"2024-01-26","current":-9.416751,"twenty":-13.905441,"median":-9.0546,"eighty":-6.166624,"marketCap":1776677287},{"date":"2024-02-02","current":-9.534775,"twenty":-13.893773,"median":-9.068239,"eighty":-6.167838,"marketCap":1798944976},{"date":"2024-02-09","current":-9.356484,"twenty":-13.878644,"median":-9.094269,"eighty":-6.192849,"marketCap":1765306552},{"date":"2024-02-16","current":-9.539797,"twenty":-13.835161,"median":-9.100679,"eighty":-6.225609,"marketCap":1799892537},{"date":"2024-02-23","current":-9.625175,"twenty":-13.830421,"median":-9.105273,"eighty":-6.230052,"marketCap":1816001078},{"date":"2024-03-01","current":-7.192485,"twenty":-13.817912,"median":-9.107687,"eighty":-6.241337,"marketCap":1735985333},{"date":"2024-03-08","current":-7.02362,"twenty":-13.807049,"median":-9.100679,"eighty":-6.252765,"marketCap":1695227829},{"date":"2024-03-15","current":-6.870463,"twenty":-13.801122,"median":-9.094269,"eighty":-6.255798,"marketCap":1658261720},{"date":"2024-03-22","current":-6.866535,"twenty":-13.794357,"median":-9.068239,"eighty":-6.258187,"marketCap":1657313871},{"date":"2024-03-28","current":-6.901879,"twenty":-13.75802,"median":-9.0546,"eighty":-6.261305,"marketCap":1665844512},{"date":"2024-04-05","current":-6.803702,"twenty":-13.722712,"median":-8.965343,"eighty":-6.267575,"marketCap":1642148288},{"date":"2024-04-12","current":-6.876353,"twenty":-13.699042,"median":-8.949082,"eighty":-6.270876,"marketCap":1659683493},{"date":"2024-04-19","current":-6.764431,"twenty":-13.676978,"median":-8.940031,"eighty":-6.285296,"marketCap":1632669799},{"date":"2024-04-26","current":-6.693743,"twenty":-13.636249,"median":-8.888993,"eighty":-6.295007,"marketCap":1615608518},{"date":"2024-05-03","current":-6.678035,"twenty":-13.606508,"median":-8.861134,"eighty":-6.300411,"marketCap":1611817122},{"date":"2024-05-10","current":-6.811556,"twenty":-13.591628,"median":-8.831645,"eighty":-6.305537,"marketCap":1644043986},{"date":"2024-05-17","current":-6.66535,"twenty":-13.56577,"median":-8.821685,"eighty":-6.320681,"marketCap":1807342945},{"date":"2024-05-24","current":-6.607374,"twenty":-13.544117,"median":-8.774994,"eighty":-6.333212,"marketCap":1791622362},{"date":"2024-05-31","current":-6.591913,"twenty":-13.536996,"median":-8.765808,"eighty":-6.33955,"marketCap":1787430207},{"date":"2024-06-07","current":-1.428017,"twenty":-13.534391,"median":-8.762512,"eighty":-6.320681,"marketCap":235088680},{"date":"2024-06-14","current":-1.458793,"twenty":-13.530648,"median":-8.74769,"eighty":-6.294936,"marketCap":240155247},{"date":"2024-06-21","current":-1.274136,"twenty":-13.527902,"median":-8.742788,"eighty":-6.264538,"marketCap":209755848},{"date":"2024-06-28","current":-1.236325,"twenty":-13.525827,"median":-8.73905,"eighty":-6.257641,"marketCap":203531210},{"date":"2024-07-05","current":-1.181807,"twenty":-13.520467,"median":-8.720695,"eighty":-6.23625,"marketCap":194556149},{"date":"2024-07-12","current":-1.1651,"twenty":-13.501419,"median":-8.701753,"eighty":-6.16711,"marketCap":191805728},{"date":"2024-07-15","current":-1.168617,"twenty":-13.494359,"median":-8.700162,"eighty":-6.163815,"marketCap":192384764},{"date":"2024-08-02","current":-1.28117,"twenty":-13.487298,"median":-8.699924,"eighty":-6.158329,"marketCap":210913921},{"date":"2024-08-09","current":-1.005943,"twenty":-13.450927,"median":-8.696095,"eighty":-6.09615,"marketCap":165604341},{"date":"2024-08-16","current":0.104301,"twenty":-13.431551,"median":-8.6648,"eighty":-6.071261,"marketCap":179428830},{"date":"2024-08-23","current":0.109307,"twenty":-13.403851,"median":-8.63741,"eighty":-5.995926,"marketCap":188041992},{"date":"2024-08-30","current":0.117049,"twenty":-13.39514,"median":-8.624442,"eighty":-5.904035,"marketCap":201359824},{"date":"2024-09-06","current":0.134972,"twenty":-13.390591,"median":-8.609648,"eighty":-5.798831,"marketCap":232193500},{"date":"2024-09-13","current":0.126894,"twenty":-13.3581,"median":-8.599787,"eighty":-5.718185,"marketCap":218296632},{"date":"2024-09-20","current":0.147174,"twenty":-13.320535,"median":-8.57594,"eighty":-5.693236,"marketCap":253183560},{"date":"2024-09-27","current":0.128998,"twenty":-13.305746,"median":-8.560338,"eighty":-5.649553,"marketCap":221915608},{"date":"2024-10-04","current":0.125211,"twenty":-13.276207,"median":-8.555407,"eighty":-5.607263,"marketCap":215401451},{"date":"2024-10-11","current":0.131102,"twenty":-13.252097,"median":-8.535683,"eighty":-5.58388,"marketCap":225534584},{"date":"2024-10-18","current":0.136066,"twenty":-13.240797,"median":-8.522393,"eighty":-5.549996,"marketCap":234075367},{"date":"2024-10-25","current":0.129334,"twenty":-13.231179,"median":-8.49513,"eighty":-5.503238,"marketCap":222494644},{"date":"2024-10-31","current":0.137076,"twenty":-13.224048,"median":-8.462226,"eighty":-5.484857,"marketCap":235812476},{"date":"2024-11-08","current":0.136824,"twenty":-13.217877,"median":-8.459506,"eighty":-5.448787,"marketCap":235378199},{"date":"2024-11-15","current":0.12003,"twenty":-13.207731,"median":-8.443665,"eighty":-5.380467,"marketCap":207439704},{"date":"2024-11-22","current":0.117098,"twenty":-13.192708,"median":-8.434596,"eighty":-5.31642,"marketCap":202373137},{"date":"2024-11-29","current":0.12782,"twenty":-13.171515,"median":-8.426987,"eighty":-5.264154,"marketCap":220902295},{"date":"2024-12-06","current":0.12648,"twenty":-13.08517,"median":-8.411844,"eighty":-5.216231,"marketCap":218586150},{"date":"2024-12-13","current":0.123548,"twenty":-13.067098,"median":-8.398818,"eighty":-5.199699,"marketCap":213519584},{"date":"2024-12-20","current":0.116261,"twenty":-13.024078,"median":-8.388445,"eighty":-5.177816,"marketCap":200925547},{"date":"2024-12-27","current":0.12514,"twenty":-13.01264,"median":-8.38282,"eighty":-5.148354,"marketCap":216270005},{"date":"2025-01-03","current":0.127736,"twenty":-12.995966,"median":-8.368365,"eighty":-5.142063,"marketCap":220757536},{"date":"2025-01-10","current":0.125475,"twenty":-12.979301,"median":-8.354397,"eighty":-5.097874,"marketCap":216849041},{"date":"2025-01-17","current":0.113413,"twenty":-12.968407,"median":-8.346533,"eighty":-5.070194,"marketCap":196003740},{"date":"2025-01-24","current":0.109644,"twenty":-12.940438,"median":-8.330294,"eighty":-5.039101,"marketCap":189489583},{"date":"2025-01-31","current":0.113497,"twenty":-12.895226,"median":-8.311208,"eighty":-4.971878,"marketCap":196148499},{"date":"2025-02-07","current":0.108471,"twenty":-12.866366,"median":-8.300882,"eighty":-4.937061,"marketCap":187462956},{"date":"2025-02-14","current":0.110063,"twenty":-12.829543,"median":-8.262624,"eighty":-4.888294,"marketCap":190213378},{"date":"2025-02-21","current":0.107215,"twenty":-12.818415,"median":-8.231392,"eighty":-4.86555,"marketCap":185291571},{"date":"2025-02-28","current":0.105539,"twenty":-12.791099,"median":-8.210935,"eighty":-4.812772,"marketCap":182396390},{"date":"2025-03-07","current":0.11157,"twenty":-12.69316,"median":-8.180554,"eighty":-4.789981,"marketCap":192819041},{"date":"2025-03-14","current":0.118522,"twenty":-12.662245,"median":-8.128541,"eighty":-4.744813,"marketCap":204834041},{"date":"2025-03-21","current":0.120949,"twenty":-12.654648,"median":-8.099523,"eighty":-4.702077,"marketCap":204110246},{"date":"2025-03-28","current":0.122836,"twenty":-12.635275,"median":-8.082172,"eighty":-4.65634,"marketCap":207294945},{"date":"2025-04-04","current":0.114344,"twenty":-12.608867,"median":-8.067817,"eighty":-4.615626,"marketCap":192963800},{"date":"2025-04-11","current":0.097102,"twenty":-12.580425,"median":-8.059594,"eighty":-4.551429,"marketCap":163867233},{"date":"2025-04-17","current":0.098389,"twenty":-12.561419,"median":-8.031854,"eighty":-4.48833,"marketCap":166038618},{"date":"2025-04-23","current":0.10182,"twenty":-12.555597,"median":-8.026649,"eighty":-4.450293,"marketCap":171828980}],"updateTime":1745543714129}}}